Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its Accurian radiofrequency nerve ablation device for treating chronic pain. “Medtronic has a long-established track record of bringing to market improved options to support clinicians with state-of-the-art technology, like the Accurian RF ablation system, which was designed for consistency and efficiency,” pain […]
Medtronic
Medtronic wins expanded FDA indication for Resolute DES
Medtronic (NYSE:MDT) said today that it won expanded FDA approval for its Resolute drug-eluting stent platform, now cleared for treating patients with coronary artery disease and de novo chronic total occlusion. The new clearance covers the Resolute Onyx and Resolute Integrity devices, the Fridley, Minn.-based company said. Read the whole story on our sister site, Drug Delivery […]
Report: Medtronic to close Portsmouth, N.H. transformative solutions facility
Medtronic (NYSE:MDT) said this week that it plans to close its Portsmouth, N.H.-based transformative solutions facility within the year, according to a Portsmouth Herald report. The Fridley, Minn.-based company recently informed employees at the facilities that it planned to eliminate its Portsmouth jobs, according to the report. The facilities currently employ 150 individuals. Medtronic spokesperson Brett Cromwell […]
Late mortality rates ‘inadvertently reversed’ in 5-year study of paclitaxel-eluting stent
The journal Circulation said this week that the all-cause mortality rates in a study comparing a paclitaxel stent and percutaneous transluminal angioplasty in people with peripheral artery disease were “inadvertently reversed” by the authors. In the first version of the paper, originally published in 2016, researchers reported that the 5-year all-cause mortality rate for people treated with Cook […]
Medtronic launches DBS for medically-refractory epilepsy in the U.S.
Medtronic (NYSE:MDT) said today that it launched its Deep Brain Stimulation system intended for medically-refractory epilepsy in the U.S. The Fridley, Minn.-based company said that the first patient was implanted with the system at Atlanta’s Emory University. “At Medtronic, we have a long-standing commitment to helping patients with medically refractory epilepsy through DBS, and we continue […]
Medtronic looks to retire up to $5b in debt
Medtronic (NYSE:MDT) today announced a cash tender offer for up to $5 billion in outstanding debt, according to recently posted SEC filing. In the offer, which is being made through Medtronic Inc. and its Covidien International Finance subsidiary, the Fridley, Minn.-based company hopes to retire $2.5 billion in 2.5% senior notes due 2020 and $600 million […]
Medtronic risk prediction tool could help prevent opioid deaths: Here’s how
Medtronic officials continue to hone their arguments for how the company’s capnography and oximetry systems could reduce potentially deadly opioid-induced respiratory compromise. The medical device giant on Feb. 17 announced preliminary results of its Prodigy study, in which the company’s Microstream and Nellcor monitoring technology provided continuous capnography and oximetry for 1,496 patients across 16 sites in the […]
Medtronic shares rise on FY2019 Q3 earnings beat
Shares in Medtronic (NYSE:MDT) are up today after the medical device giant posted third quarter fiscal year 2019 earnings that beat expectations on Wall Street. The Fridley, Minn.-based company posted profits of approximately $1.27 billion, or 94¢ per share, on sales of approximately $7.55 billion for the three months ended January 25, seeing a swing from […]
Medtronic: Patient deaths left out of paclitaxel-coated balloon analysis
Medtronic (NYSE:MDT) said last week that it inadvertently omitted an undisclosed number of patient deaths from recent studies of its paclitaxel-coated balloons. The company noted that the mistake ultimately does not affect the conclusion that there was no statistically significant difference in all-cause mortality between its In.Pact Admiral drug-coated balloon and plain balloon angioplasty at five years. Get […]
Medtronic wins FDA’s breakthrough status for closed-loop insulin system
Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Get the full story at our sister site, Drug Delivery Business News.
Medtronic inks 5-year value-based healthcare deal with S.C. hospital
Medtronic (NYSE:MDT) said today that it inked a five-year value-based healthcare partnership deal with the Medical University of South Carolina, looking to improve health outcomes, patient care experiences and reduce costs. Fridley, Minn.-based Medtronic said the partnership will initially focus on addressing chronic disease and acute conditions prevalent in the region. An initial program involves standardizing […]